- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
February 17, 2020
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.
February 14, 2020
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population.
February 14, 2020
Advancing serum peptidomic profiling by data-independent acquisition for clear-cell renal cell carcinoma detection and biomarker discovery.
February 14, 2020
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In Vitro.
February 13, 2020
Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
February 13, 2020
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma.
February 11, 2020
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
February 11, 2020
NK Cell-Based Immunotherapy in Renal Cell Carcinoma.
February 11, 2020
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.
February 10, 2020
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma.
February 10, 2020
Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report.
February 7, 2020
SEOM clinical guideline for treatment of kidney cancer (2019).
February 7, 2020